Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
Latest Podcasts
BS Medicine Episode #597: Insomnia – hours of sleep is not the goal!
In episode 597, James and Mike invite David Gardner to talk in depth about the issue of insomnia. We talk about triggers, precipitating factors, acute and chronic insomnia, and chronic…
BS Medicine Episode #596: PREMIUM – A painful podcast about methotrexate and walking for pain
In episode 596, Mike and James talk in a PREMIUM way about three trials that used methotrexate for osteoarthritis and walking for back pain. Nothing miraculous but there seems to…
BS Medicine Episode #595: How to slow the flow: Combined oral contraceptives
In episode 595, Mike and James invite Jennifer Young back to talk about the use of combined oral contraceptives for heavy menstrual bleeding (benign etiology) and see if they improve…
September 19, 2024
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
Please provide any additional comments (optional).